Showing results (501-510 of 654) with videos related to

Sort By:
Pageof 66
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 27, 2026
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
International Urology and Nephrology|June 13, 2026
Abdominal waist circumference and subcutaneous adipose tissue thickness predicts development of post-transplant diabetes mellitusMehmet Kanbay, Feyyaz H Yagmur, Bilge Karadeniz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2025
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trialMuthiah Vaduganathan, Jennifer B Green, Hiddo J L Heerspink, et al.
Cardiovascular Research|February 21, 2020
Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locusAnni A V Antikainen, Niina Sandholm, David-Alexandre Trégouët, et al.
Diabetes Care|September 19, 2025
Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial)Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Diabetes Care|January 20, 2023
Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD StudyJelle M Beernink, Frederik Persson, Niels Jongs, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup AnalysesDavid Z I Cherney, Peter Rossing, Maria Eugenia Canziani, et al.
Iscience|October 31, 2025
Current advances in diabetic neuropathy: Proteins as therapeutic targetsGurjeet Kaur, Salaha Osman Ali, Alberto Santos, et al.
Journal of Diabetes Research|July 15, 2015
Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular DysfunctionKarin G F Gerritsen, Jan Willem Leeuwis, Maarten P Koeners, et al.
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Pageof 66